Removal of parvovirus B19 from contaminated factor VIII during fractionation

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

A solution of pooled cryo‐precipitate for preparing factor Vlll (F VIII) by the solventi/detergent method was contaminated experimentally with parvovirus B19‐positive plasma to evaluate virus reduction achieved by the final steps of the F Vlll production process. Virus reduction was at least 2 logs of the total amount of B19 virus added to the pooled cryo‐precipitate. The major amount of B19 virus was detected in the solution used to regenerate the F VIII‐selective anion exchange chromatography column. A few viral particles were detected in the final F Vlll concentrate before filtration but these were aggregates and were removed by filtration, and in the solution used to regenerate the anion exchange resin. It is not known whether the residual viral DNA present in the final product represents infectious or inactivated particles.

Original languageEnglish
Pages (from-to)28-31
Number of pages4
JournalJournal of Medical Virology
Volume35
Issue number1
DOIs
StatePublished - Sep 1991
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • anion exchange ehromatography
  • blood derivates
  • parvovirus
  • virus inactivation

Fingerprint

Dive into the research topics of 'Removal of parvovirus B19 from contaminated factor VIII during fractionation'. Together they form a unique fingerprint.

Cite this